Prescription drug savings from Novo Nordisk

Novo Nordisk is a leading global healthcare company dedicated to improving the lives of people with chronic conditions like diabetes, obesity, and rare bleeding disorders. As part of its commitment to patient care, Novo Nordisk offers a Patient Assistance Program (PAP) that provides eligible individuals with access to vital medications they need to manage their conditions. In this comprehensive guide, we will explore the Novo Nordisk PAP in detail, including the available products, eligibility criteria, and application process.

How the Patient Assistance Program works

NovoCare’s Patient Assistance Programs are designed to provide eligible patients with access to Novo Nordisk medications at reduced or no cost. Through these programs, individuals facing financial hardships can receive the support they need to continue their treatment without undue burden. NovoCare’s commitment to patient well-being is exemplified through these assistance programs, which aim to improve medication adherence and overall health outcomes.

Applying for the Novo Nordisk Patient Assistance Program

The Novo Nordisk Patient Assistance Program offers both online and paper application options. Applying online is a fast and easy process that provides step-by-step guidance. However, individuals can also choose to apply by paper. It’s important to verify the email address of the healthcare provider before starting the application, as they will receive a copy of the form and need to complete certain sections.

Online application process

To apply online for the Patient Assistance Program, follow these steps:

• Before starting the application, ensure that you have the correct email address of your healthcare provider. They will receive a copy of the application form and need to complete specific sections
• Before starting the application, ensure you have the necessary documents, such as your tax documents from the most recent year, proof of income, and Medicare insurance card(s)
• Visit the Novo Nordisk website and follow the step-by-step process for the online application. Please note that the online application is available in English only

Paper application process

If you prefer to apply by paper, follow these steps:

• Download the application form from the Novo Nordisk website. Complete all the required sections, including Patient Information, Insurance, Income, Medicare Part D consent (if applicable), Patient Declaration, Authorization, Consent to be Contacted, and the Fair Credit Reporting Act (FCRA) Consent
• Make copies of your adjusted gross annual household income, such as paycheck stubs, earning statements, federal tax returns, Social Security income statements, W-2 or 1099 forms, or unemployment benefit statements
• Take the completed application and proof of income to your healthcare provider. They will need to complete the Prescriber and Rx sections of the application, sign and date it. The application and proof of income can be faxed to 1-866-441-4190 or mailed to Novo Nordisk Inc., PO Box 370, Somerville, NJ 08876. Faxes must be sent from the healthcare provider’s office

Once the application is submitted, it may take up to 10 business days for processing. Both the applicant and the healthcare provider will be notified of the decision. If approved, the medication will be sent to the healthcare provider’s office for pickup.

Eligibility criteria for the Patient Assistance Program

To be eligible for the Novo Nordisk Patient Assistance Program, individuals must meet the following criteria:

• Participants must be either US citizens or legal residents of the United States
• The total household income should not exceed 400% of the Federal Poverty Level (FPL). The current FPL guidelines can be found on the NeedyMeds website
• Applicants must either have Medicare or no insurance coverage
• Participants should not be enrolled in or eligible for any other federal, state, or government programs such as Medicaid, Low Income Subsidy, or Veterans Affairs (VA) Benefits

Individuals eligible for Medicaid, must sign the Patient Declaration section of the latest version of the PAP application, stating that they are not enrolled in, plan to enroll in, or are eligible for Medicaid or Medicare Extra Help/LIS. Proof of denial may be required if requested.

Additional options for residents of specific states

Apart from the general Patient Assistance Program, residents of Colorado, Maine, and Minnesota may have access to additional assistance through the State Insulin Safety Net Program.

Access to a wide range of medications

Novo Nordisk offers a wide range of prescription drugs through its Patient Assistance Program, catering to different conditions and treatment needs.

Novo Nordisk is a renowned leader in insulin production, offering a variety of insulin formulations. These medications play a vital role in managing diabetes and maintaining blood sugar levels. The PAP also provides access to GLP-1 receptor agonists like Victoza and Ozempic, which help control blood glucose levels and promote weight loss in people with type 2 diabetes.

Novo Nordisk is committed to supporting individuals with hemophilia, providing access to treatments like NovoSeven and Rebinyn, which help control bleeding episodes in people with hemophilia A and B.

Obesity Medication for chronic weight management is also available through the Novo Nordisk PAP. It aids in weight loss and can be a valuable tool in managing obesity.

The Patient Assistance Program offers access to the following prescription medications:

Diabetes

• Ozempic® (semaglutide injection) 0.5 mg, 1 mg, or 2 mg
• RYBELSUS® (semaglutide) tablets
• Victoza® (liraglutide injection) 1.2 mg or 1.8 mg
• Xultophy® 100/3.6 (insulin degludec & liraglutide injection) 100 U/mL & 3.6 mg/mL
• Fiasp® (insulin aspart) injection 100 U/mL
• Novolin® (human insulin [rDNA origin] injection) 100 U/mL
• NovoLog® (insulin aspart) injection 100 U/mL
• NovoLog® Mix 70/30 (insulin aspart protamine and insulin aspart injectable suspension) 100 U/mL
• Tresiba® (insulin degludec) injection 100 U/mL, 200 U/mL
• NovoPen® Echo
• Disposable Needles (only available for FlexPen®, FlexTouch®, Victoza® and Xultophy® 100/3.6)
• Zegalogue® (dasiglucagon) injection 0.6 mg/0.6 mL

Obesity

• Saxenda® (liraglutide) injection 3 mg
• Wegovy® (semaglutide) injection 2.4 mg

Rare blood disorders

• NovoSeven® RT
• Novoeight®
• Tretten®
• Rebinyn®
• Esperoct®

Growth related disorders

• Norditropin®
• Sogroya®

Resources and education

NovoCare extends its commitment to patient support and resources beyond financial help.

Diabetes

NovoCare offers a wealth of resources to support individuals with diabetes in managing their condition effectively. The NovoCare diabetes resources encompass educational materials, lifestyle tips, nutrition guidance, and information on the latest advancements in diabetes management. Additionally, NovoCare provides access to diabetes organizations that offer further support and community engagement opportunities for patients.

Obesity

NovoCare recognizes the challenges faced by individuals struggling with obesity and offers a range of resources to support their journey towards a healthier weight. Through NovoCare, patients can access informative materials, tools for tracking progress, and practical tips for managing their weight effectively. Furthermore, Novo Nordisk’s commitment to combating obesity extends to clinical trials aimed at pioneering innovative solutions in this field.

Hemophilia

NovoCare offers educational materials on hemophilia management, including information on treatment options, self-care techniques, and tips for maintaining an active lifestyle. Moreover, NovoCare connects patients to clinical trials and assistance programs that can alleviate the financial burden associated with hemophilia treatment.

Growth Hormone-Related Disorders

Through NovoCare, patients can access educational materials on growth hormone-related disorders, including information on diagnosis, treatment options, and lifestyle management. NovoCare also facilitates enrollment in clinical trials aimed at advancing treatment options for these conditions.

Women’s Health

NovoCare recognizes the importance of addressing women’s health issues and offers resources specifically tailored to support women in their healthcare journey. Whether it’s reproductive health, hormone-related disorders, or pregnancy management, NovoCare provides educational materials, support programs, and assistance resources to empower women in making informed healthcare decisions.

Resources and Support for Patients | Novo Nordisk U.S. (novonordisk-us.com)

Conclusion

The Novo Nordisk Patient Assistance Program plays a vital role in ensuring that individuals facing financial challenges can access the medications they need to manage their chronic conditions effectively. By offering a wide range of products and simplifying the application process, Novo Nordisk demonstrates its commitment to improving patient outcomes and making a positive difference in the lives of those it serves. If you or someone you know is struggling to afford necessary medications, exploring the Novo Nordisk PAP could be a step towards a healthier future. Reach out to Novo Nordisk today to learn more about the program and how it can provide the support you need.

Sources

• Ozempic® (semaglutide injection) 0.5 mg, 1 mg, or 2 mg
• RYBELSUS® (semaglutide) tablets